Celestica's Stunning Guidance Raise Tests Credibility of AI Growth Blueprint

What happened

Celestica management sharply raised 2026 outlook to $21B revenue and $11.55 EPS, and introduced 2027 guidance of $40B revenue and $21.50 EPS, citing explosive demand from AI and scale-up Ethernet networking. The new 2026 revenue target is a $2B jump from the $19B guided just three months ago, implying a massive second-half acceleration as 1.6T switch programs begin to ship. While the stock likely reacted positively, the guidance assumes flawless execution, continued hyperscaler spending, and a near-doubling of annual revenue with minimal margin degradation. The article's claim that management is understating is suspect given the scale of the raise; it may be a promotional take from Seeking Alpha. The core risks from the master report—customer concentration, flat gross margins, inventory buildup, and dilution from the August equity raise—remain unresolved.

Implication

The raised guidance materially strengthens the bull case, as it suggests hyperscaler demand is even stronger than previously thought and that management has line of sight to 1.6T ramp and capacity utilization. However, the jump from $19B to $21B in 2026 and the $40B 2027 target are aggressive and rely on perfect execution, continued AI capex growth, and no share loss at top customers. With top-10 customers already at 83% of revenue and three CCS customers representing 32%, 17%, and 14% of Q2 sales, any program delay could cause a sharp miss. Gross margin has not expanded despite revenue growth, and the equity raise added ~9.7% dilution, so per-share improvements depend on operating leverage that has yet to materialize. Investors should treat the guidance as a positive data point but demand concrete evidence—such as 1.6T revenue contribution and margin improvement in the next two quarters—before paying a premium valuation. The stock is now likely trading above the base case fair value of $355 and approaching bull case territory, leaving little room for error.

Thesis delta

The thesis shifts from a cautious WAIT based on unproven 1.6T ramp to a marginally more positive but still uncertain stance. The new guidance suggests stronger visibility and supports the bull case, but it also raises the execution bar and may be overly optimistic given margin and concentration risks. We maintain a WAIT but acknowledge that if the next quarter confirms the acceleration, the rating could move to BUY.